<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02323672</url>
  </required_header>
  <id_info>
    <org_study_id>chemerin_MMP-9_Oral_cancer</org_study_id>
    <nct_id>NCT02323672</nct_id>
  </id_info>
  <brief_title>Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions</brief_title>
  <official_title>Salivary and Serum Levels of Chemerin and MMP-9 in Oral Precancer and Oral Squamous Cell Carcinoma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15
      patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9
      were evaluated in serum and saliva of these subjects utilizing the ELISA technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      45 individuals were subdivided into 3 groups, 15 patients suffering from oral premalignant
      lesions, 15 patients suffering from oral malignant lesions and 15 individuals having age,
      gender and periodontal status matched with both patients groups acting as a control group.
      Serum and whole unstimulated saliva samples were collected from all the included groups in
      order to determine chemerin and MMP-9 in serum and saliva utilizing the ELISA technique.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>salivary levels of chemerin in patients with oral premalignant and malignant lesions.</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum levels of chemerin in patients with oral premalignant and malignant lesions.</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum levels of MMP-9 in patients with oral premalignant and malignant lesions.</measure>
    <time_frame>morning visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>salivary levels of MMP-9 in patients with oral premalignant and malignant lesions.</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Precancerous Conditions</condition>
  <condition>Oral Cancer</condition>
  <arm_group>
    <arm_group_label>oral premalignant patients</arm_group_label>
    <description>15 patients suffering from oral premalignant lesions as lichen planus, actinic keratosis, leukoplakia and erythroplakia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oral malignant patients</arm_group_label>
    <description>15 patients suffering from oral malignant lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control subjects</arm_group_label>
    <description>15 individuals age, gender and periodontal status matched with oral premalignant and malignant patients and not suffering from any oral mucosal lesions or periodontal disease.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum and whole unstimulated saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        45 individuals were subdivided into 3 groups, 15 patients suffering from oral squamous cell
        carcinoma lesions, 15 patients suffering from oral premalignant lesions (OPL) and 15
        individuals having age, gender and periodontal status matched with both patients groups
        acting as a control group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with oral premalignant lesions.

          -  patients with oral malignant lesions.

        Exclusion Criteria:

          -  any systemic disease other than oral premalignant or malignant lesions. smokers.
             pregnant females. periodontal diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noha Ghallab, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor of periodontology and Oral Medicine faulty of oral and dental medicine Cairo Unv.</affiliation>
  </overall_official>
  <reference>
    <citation>Skrzeczyńska-Moncznik J, Stefańska A, Zabel BA, Kapińska-Mrowiecka M, Butcher EC, Cichy J. Chemerin and the recruitment of NK cells to diseased skin. Acta Biochim Pol. 2009;56(2):355-60. Epub 2009 Jun 18.</citation>
    <PMID>19543554</PMID>
  </reference>
  <reference>
    <citation>Parolini S, Santoro A, Marcenaro E, Luini W, Massardi L, Facchetti F, Communi D, Parmentier M, Majorana A, Sironi M, Tabellini G, Moretta A, Sozzani S. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007 May 1;109(9):3625-32. Epub 2007 Jan 3.</citation>
    <PMID>17202316</PMID>
  </reference>
  <reference>
    <citation>Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol. 2001 Feb;28(2):72-82.</citation>
    <PMID>11168755</PMID>
  </reference>
  <reference>
    <citation>Nanda DP, Dutta K, Ganguly KK, Hajra S, Mandal SS, Biswas J, Sinha D. MMP-9 as a potential biomarker for carcinoma of oral cavity: a study in eastern India. Neoplasma. 2014;61(6):747-57. doi: 10.4149/neo_2014_091.</citation>
    <PMID>25150320</PMID>
  </reference>
  <reference>
    <citation>Wang N, Wang QJ, Feng YY, Shang W, Cai M. Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue. Clin Oral Investig. 2014 Apr;18(3):997-1004. doi: 10.1007/s00784-013-1046-8. Epub 2013 Jul 19.</citation>
    <PMID>23868294</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2014</study_first_submitted>
  <study_first_submitted_qc>December 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>February 9, 2017</last_update_submitted>
  <last_update_submitted_qc>February 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Noha Ayman Ghallab</investigator_full_name>
    <investigator_title>Associate Professor of periodontology and Oral Medicine, faculty of oral and dental medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Neoplasms</mesh_term>
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

